Abstract 926: Extrinsic and intrinsic activation of RAS/MAPK signaling enables resistance to FLT3 inhibitor, gilteritinib, in acute myeloid leukemia

v1

Sunil K. Joshi, Stephen Christy, Renata Scopim Ribeiro, Shannon K. McWeeney and 4 more

Sunil K. Joshi

Type:Journal Article

Sign in to see the full record

Creating an account is free.

For data access, contact info@nobleid.org.